Thrombolysis in Myocardial Infarction Study Group

Recent papers from Thrombolysis in Myocardial Infarction Study Group

1. Clear Target, Multiple Paths: Rethinking Intensive LDL-C LoweringCirculation · 2026
2. Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of FallingJournal of the American College of Cardiology · 2016
3. Abstract 15320: The Association of the Human Development Index with Global Outcomes with Direct Oral Anticoagulants versus Warfarin in Atrial Fibrillation: An Individual Patient-Level Meta-Analysis of 4 RCTs Across 52 Countries and 58,015 Patients from COMBINE-AFCirculation · 2026
4. Common Genetic Variants Near SLC2A2 and Glycemic Response to Glimepiride in the GRADE Comparative Effectiveness Clinical TrialDiabetes Care · 2026
5. Eugene Braunwald Legacy Series: Lipid Lowering and the Era of PreventionCirculation · 2026
6. Tackling Acute Myocardial InfarctionCirculation · 2026
7. A Lasting Legacy: Honoring the Life and Impact of Dr Eugene BraunwaldCirculation · 2026
8. Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 InhibitorsJournal of the American College of Cardiology · 2020
9. Myocardial infarction accelerates atherosclerosisNature · 2012
10. Evolocumab and risk of a first myocardial infarction: a prespecified analysis of the VESALIUS-CV trialEuropean Heart Journal · 2026
11. Proteomic changes associated with vupanorsen therapy in TRANSLATE-TIMI-70European Heart Journal · 2026
12. Proteomic signatures reveal why not all apolipoprotein B-containing lipoproteins are equal in atherosclerosisEuropean Heart Journal · 2026
13. Management of Coronary Stent UnderexpansionJournal of the American College of Cardiology · 2025
14. Modulation of Myocardial EnergeticsCirculation · 2005
15. Confounders, Effect Modifiers, and Mediators: Dealing With “Third Variables” in Cardiovascular EpidemiologyCirculation · 2025
16. A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskJournal of the American College of Cardiology · 2025
17. Impact of Optical Coherence Tomography-Based Post-PCI Physiology Assessment to Predict Clinical OutcomesJournal of the American College of Cardiology · 2025
18. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trialsThe Lancet · 2015
19. PRAGUE-26 in perspective: convincing early stabilization, but durable benefit remains unprovenEuropean Heart Journal Acute Cardiovascular Care · 2026
20. Dapagliflozin in Patients With Heart Failure Across the Care SpectrumJACC Heart Failure · 2026